Activation of Serine One-Carbon Metabolism by Calcineurin Aβ1 Reduces Myocardial Hypertrophy and Improves Ventricular Function

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

卷:71

Article

Padron-Barthe, Laura^1,2,3  Villalba-Orero, Maria^1,3  Gomez-Salinero, Jesus M.¹  Acin-Perez, Rebeca¹  Cogliati, Sara¹  Lopez-Olaneta, Marina¹  Ortiz-Sanchez, Paula¹  Bonzon-Kulichenko, Elena^1,3  Vazquez, Jesus^1,2  Garcia-Pavia, Pablo^2,3,4  Rosenthal, Nadia^5,6  Antonio Enriquez, Jose¹  Lara-Pezzi, Enrique^1,3,6 

[1] Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain

[2] Hosp Univ Puerta de Hierro, Dept Cardiol, Heart Failure & Inherited Cardiac Dis Unit, Madrid, Spain

[3] Ctr Invest Biomed Red Cardiovasc CIBERCV, Madrid, Spain

[4] UFV, Fac Ciencias Salud, Madrid, Spain

[5] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA

[6] Imperial Coll London, Natl Heart & Lung Inst, London, England

关键词: cardiac function;    cell signaling;    hypertrophy;    metabolism;   

DOI  :  10.1016/j.jacc.2017.11.067

来源: Elsevier

【 摘 要 】

BACKGROUND In response to pressure overload, the heart develops ventricular hypertrophy that progressively decompensates and leads to heart failure. This pathological hypertrophy is mediated, among others, by the phosphatase calcineurin and is characterized by metabolic changes that impair energy production by mitochondria. OBJECTIVES The authors aimed to determine the role of the calcineurin splicing variant CnA beta 1 in the context of cardiac hypertrophy and its mechanism of action. METHODS Transgenic mice overexpressing CnAb1 specifically in cardiomyocytes and mice lacking the unique C-terminal domain in CnA beta 1 (CnA beta 1(Delta i12) mice) were used. Pressure overload hypertrophy was induced by transaortic constriction. Cardiac function was measured by echocardiography. Mice were characterized using various molecular analyses. RESULTS In contrast to other calcineurin isoforms, the authors show here that cardiac-specific overexpression of CnA beta 1 in transgenic mice reduces cardiac hypertrophy and improves cardiac function. This effect is mediated by activation of serine and one-carbon metabolism, and the production of antioxidant mediators that prevent mitochondrial protein oxidation and preserve ATP production. The induction of enzymes involved in this metabolic pathway by CnAb1 is dependent on mTOR activity. Inhibition of serine and one-carbon metabolism blocks the beneficial effects of CnA beta 1. CnA beta 1(Delta i12) mice show increased cardiac hypertrophy and declined contractility. CONCLUSIONS The metabolic reprogramming induced by CnAb1 redefines the role of calcineurin in the heart and shows for the first time that activation of the serine and one-carbon pathway has beneficial effects on cardiac hypertrophy and function, paving the way for new therapeutic approaches. (J Am Coll Cardiol 2018; 71: 654-67) (C) 2018 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).

【 授权许可】

Free